Advertising


News

In Practice: Upcoming off-label prescribing webinar


Michelle Wisbey


17/09/2026 4:27:26 PM

It aims to help GPs understand the risks, benefits and necessity of off-label prescribing, while recognising the ‘gravity it deserves’.

GP speaking to a patient.
An upcoming webinar will discuss and explore off-label prescribing and its role in GPs’ daily practice.

This week’s In Practice also includes information on a webinar on tongue, lip and cheek ties, a new culturally and linguistically diverse specific populations resource, and a care and management plans member meeting.
 
Off-label prescribing in Australia 
Webinar: Thursday 24 September, 7.00 – 8.30 pm (AEST) 
CPD: 1.5 EA hour 
Register online 
 
This webinar will discuss and explore off-label prescribing and its role in GPs’ daily practice. This session aims to develop an understanding of the risks, benefits and necessity of off-label prescribing, while recognising the gravity it deserves and the need for specific procedures depending on the treatment and clinical situation. 
  
Join this panel to discuss what constitutes an appropriate consent process, whether additional monitoring is required based on the available evidence, and how these principles apply across different craft groups and medications. The session will explore how GPs should approach their practice and medico-legal responsibilities when prescribing off-label, particularly in evidence-poor areas. 
 
Care and management plans member meeting 
As part of the RACGP’s Medicare CPD project with the Department of Health, Disability and Ageing, it will be hosting a targeted member meeting on Tuesday 6 October on MBS care and management plans.
 
Attendance is capped at 40 members and is the first of four targeted meetings. The session will be recorded for those who cannot attend. 
 
Tongue, lip and cheek ties 
Webinar: Wednesday, 23 September, 7.30 – 8.30 pm (AEST) 
CPD: 1 EA hour 
Register online 
 
This webinar provides a concise, evidence-based overview of tongue, lip, and buccal ties in infants, delivered from an ENT perspective. It will focus on assessment of oral restrictions, their functional impact, and appropriate management pathways. Key topics include: 

  • clinical presentation and functional impact on feeding, growth, and maternal symptoms 
  • differentiating normal anatomical variation from clinically significant restriction 
  • structured approach to assessment, including history and examination 
  • indications for conservative management versus surgical intervention 
  • referral pathways and multidisciplinary car, including ENT involvement
  • risks, benefits, and expected outcomes of procedures 
  • common pitfalls, including overdiagnosis and unnecessary intervention.
Designed for primary care clinicians, this session aims to support accurate assessment, reduce variability in care, and promote safe, evidence-based management aligned with current clinical guidance. 

Culturally and linguistically diverse specific populations resource 
The General Practice Mental Health Standards Collaboration has developed a new suite of resources to assist GPs in providing inclusive, trauma-informed and culturally safe care to patients from diverse backgrounds. One such resource addresses culturally and linguistically diverse (CALD) patients. 
 
The resource offers advice on providing trauma-informed and culturally safe care to CALD patients, including practical tips to build trust, ask sensitive questions respectfully, and recognise when to proceed with caution.  
 
The resource also features tailored information around the unique challenges CALD patients face, such as cultural and familial circumstances, migration history, systemic barriers, interpreter services, specific administrative processes and more. 
 
You can read more about the resource here or find the full suite of specific populations resources here. 
 
Log in below to join the conversation.


CALD care plans culturally and linguistically diverse off-label prescribing


newsGP weekly poll Have you ever found out that a patient has previously failed to disclose their use of GLP-1 medicines to you as their usual GP?
 
56%
 
38%
 
5%
Related



newsGP weekly poll Have you ever found out that a patient has previously failed to disclose their use of GLP-1 medicines to you as their usual GP?

Advertising

Advertising

 

Login to comment